Beijing Beilu Pharmaceutical Co., Ltd (SZSE:300016) Signed a Letter of intent to acquire 80% stake in Chengde Tianyuan Pharmaceuticals Co.,Ltd from Goldenmax International Group Ltd. (SZSE:002636) for CNY 248 million on February 29, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 CNY | -0.96% | +2.11% | -18.63% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
7.25 CNY | -0.96% | +2.11% | 737M | ||
5.03 CNY | -0.98% | -0.59% | 345M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.63% | 737M | |
+91.22% | 2,331B | |
+41.82% | 671B | |
+25.44% | 655B | |
+11.67% | 269B | |
+39.04% | 221B | |
+16.74% | 181B | |
+49.21% | 143B | |
-36.95% | 137B | |
+50.00% | 115B |
- Stock Market
- Equities
- 002636 Stock
- News Goldenmax International Group Ltd.
- Beijing Beilu Pharmaceutical Co., Ltd Signed a Letter of intent to acquire 80% stake in Chengde Tianyuan Pharmaceuticals Co.,Ltd from Goldenmax International Group Ltd. for CNY 248 million.